Sector: Pharmaceuticals & Biotechnology

Large Cap

Gland Pharma Share Price

Gland Pharma Ltd.

₹1,803

-18.70(-1.03%)

Invest in GLAND with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : GLAND

Open Free Demat Account

Gland Pharma Performance

Price Movement

₹1803.00

₹1799.20

₹1845.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1803.00

₹1277.80

₹2131.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,845.00

Low₹1,799.20

Open at₹1,845.00

Prev Close₹1,821.70

Volumes28.20 K

Avg Price₹1,810.10

Lower Circuit₹1,457.40

Upper Circuit₹2,186.00

Historical Performance

3M High₹1,984.90

3M Low₹1,629.60

1 Yr High₹2,131.00

1 Yr Low₹1,277.80

3 Yr High₹2,220.95

3 Yr Low₹861.00

5 Yr High₹4,350.00

5 Yr Low₹861.00

Gland Pharma Fundamentals

Market Cap

High in industry

29,702.30 Cr.

PE Ratio (TTM)

Above industry Median

35.10

Dividend Yield

Above industry Median

Net Profit TTM

20.3% incr over last year

847.18

Net Profit Growth

20.3% incr over last year

847.18

PEG Ratio

High in industry

1.70

ROE

14% decr over last year

7.63

Operating Revenue TTM

6,112.77

Operating Revenue Growth

6.7% incr over last year

Book Value

Above industry Median

3.10

MFI

MFI is mid-range

67.88

RSI

RSI is mid-range

52.51

EPS (TTM)

42.40

Debt to Equity

0.03

Face Value

Operating Profit Margin Qtr.

21.77

Operating Profit Qtr.

434.88

Net Profit Qtr.

261.48

Operating Revenue Qtr.

1,695.36

PB Ratio

3.10

Gland Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	1,177.51	1,074.15	1,038.84	1,030.35	1,010.78
Operating Expense	755.89	699.26	679.99	636.23	619.64
Operating Profit	421.63	374.89	358.84	394.12	391.14
Depreciation	44.53	44.84	43.77	43.07	43.77
Interest	0.50	3.97	7.44	3.45	18.31
Tax	104.61	106.68	93.12	101.32	99.01
Net Profit	307.85	302	269.26	290	295.12

Gland Pharma Technicals

Gland Pharma Ltd. EMA & SMA

₹1803.00

-18.70 (-1.03%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1831.5

Day EMA10 ₹1832.4

Day EMA12 ₹1830.7

Day EMA20 ₹1817.7

Day EMA26 ₹1807.5

Day EMA50 ₹1789.6

Day EMA100 ₹1794.6

Day EMA200 ₹1789.5

Gland Pharma Support and Resistance

Resistance

First Resistance₹1835.37

Second Resistance₹1849.03

Third Resistance₹1859.97

Support

First Support₹1810.77

Second Support₹1799.83

Third Support₹1786.17

Technical Indicators

Day RSI52.51

Day MFI67.88

Day ADX22.42

Day Commodity Channel Index-7.80

William-69.15

Day MACD23.15

Day MACD Signal Line29.41

Day ATR55.20

Day ROC125-6.33

Day ROC215.71

Gland Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	4.5	5	6.9	7.4	7.9	7.6
DII	35.3	34.8	33.3	32.8	32.6	33
Public	8.3	8.3	8	7.9	7.6	7.6

Gland Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	6.96 K	17.15 K	40.57%
Week	32.94 K	60.63 K	54.33%
1 Month	91.55 K	2.7 L	33.95%
6 Month	1.04 L	1.9 L	54.84%

Gland Pharma SWOT Analysis

Strengths18

Weakness8

Opportunity9

Threats2

Benjamin Graham Value Screen

Stocks in Buy Zone with High Momentum Score Last Month

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Negative to Positive growth in Sales and Profit with Strong Price momentum

Stocks Outperforming their Industry Price Change in the Quarter

Gland Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
14 Aug, 2025	18	FINAL	14 Aug, 2025	Equity Share
16 Aug, 2024	20	FINAL	16 Aug, 2024	Equity Share

Gland Pharma Stock Comparison

Financials	Anthem Biosciences Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Laurus Labs Ltd.
Price (₹)	₹696.90	₹1,431.80	₹2,045	₹162	₹1,014.60
% Change	2.20%	-0.42%	1.02%	0.92%	-0.43%
Revenue TTM (₹ Cr)	₹1,996.59	₹8,850.08	₹13,914.08	₹8,871.37	₹6,721.63
Net Profit TTM (₹ Cr)	₹484.66	₹869.92	₹1,779.35	₹-163.61	₹843.32
PE TTM	80.70	31.30	47.50	-131.70	65.10
1 Year Return	22.17	44.17	-12.08	-22.44	95.04
ROCE	26.88	20.80	13.27	6.40	11.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6258.50

-0.52%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2975.00

+1.21%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

IPCALAB

Ipca Laboratories Ltd.

₹ 1469.70

+1.37%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2635.30

+1.48%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on GLAND

What is the current share price of Gland Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Gland Pharma Ltd. is ₹ 1803 on the NSE and ₹ 1805 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Gland Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Gland Pharma Ltd. is approximately ₹ 29702.3 Cr.

What are the PE and PB ratios for Gland Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Gland Pharma Ltd. is 35.1, and the Price-to-Book (PB) ratio is 3.1.

What is the 52-Week High and Low for Gland Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Gland Pharma Ltd. shares was ₹ 2131, and the lowest price was ₹ 1277.8.

What is the current dividend yield for Gland Pharma Ltd.?

As of 6 June 2025, the dividend yield for Gland Pharma Ltd. is 1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Gland Pharma Ltd.?

Significant shareholdings in Gland Pharma Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Gland Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Gland Pharma Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Gland Pharma Ltd.?

Gland Pharma Ltd. last declared a FINAL dividend of ₹ 18 per share for the financial period ending 2025. The record date was set as 2025-08-14, and the payment was/is scheduled around 2025-08-14. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy